Key result
5-FU and cisplatin infusion triggers serious ventricular dysrhythmias and silent myocardial ischemia in case report.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
The antimetabolite 5-fluorouracil is frequently used in the therapy of various malignancies. Cardiotoxicity has frequently been described during treatment, but there is no common agreement on the need to perform cardiovascular monitoring of patients during 5-fluorouracil administration. We report the case of a young patient with an head-neck cancer on whom a continuous electrocardiogram recording was performed, documenting serious ventricular dysrhythmias in the presence of myocardial ischemia during 5-fluorouracil and cis-platin infusion.
No takes yet. Share an insight, caveat, or question.
Hrovatin et al. (2006) conducted a case report in Head-neck cancer with 5-fluorouracil cardiotoxicity (n=1). 5-fluorouracil and cisplatin infusion was evaluated on Serious ventricular dysrhythmias and silent myocardial ischemia on continuous ECG. 5-fluorouracil and cisplatin infusion induced serious ventricular dysrhythmias and silent myocardial ischemia documented on continuous ECG in 1 young patient with head-neck cancer.
Synapse has enriched 10 related papers. Consider them for comparative context: